Tech Company Financing Transactions

ZIOPHARM Oncology Funding Round

Private investors participated in a $19.5 million funding round for ZIOPHARM Oncology. The round was announced on 9/18/2019.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Proceeds Purpose
Proceeds purposes were not disclosed. 1 investor participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Mailing Address
1 First Ave. Parris Building 34
Boston, MA 02129
Email Address
Operations were initiated in January 2004 with the strategy of in-licensing proprietary drug candidate families with prior related-molecule efficacy in human cancer that would be efficiently and effectively developed and commercialized by a very experienced management team supported by prominent clinicians and medical advisors.
ZIOPHARM Oncology LinkedIn Company Profile
Social Media
ZIOPHARM Oncology Company Twitter Account
Company News
ZIOPHARM Oncology News
ZIOPHARM Oncology on Facebook
ZIOPHARM Oncology on YouTube

Management Team

Email & Social
Chief Executive Officer
Laurence Cooper
  Laurence Cooper LinkedIn Profile  Laurence Cooper Twitter Account  Laurence Cooper News  Laurence Cooper on Facebook
Chief Financial Officer
Satyavrat Shukla
  Satyavrat Shukla LinkedIn Profile  Satyavrat Shukla Twitter Account  Satyavrat Shukla News  Satyavrat Shukla on Facebook
David Mauney
  David Mauney LinkedIn Profile  David Mauney Twitter Account  David Mauney News  David Mauney on Facebook
VP - Bus. Development
Eleanor de Groot
  Eleanor de Groot LinkedIn Profile  Eleanor de Groot Twitter Account  Eleanor de Groot News  Eleanor de Groot on Facebook
VP - General Counsel
Robert Hadfield
  Robert Hadfield LinkedIn Profile  Robert Hadfield Twitter Account  Robert Hadfield News  Robert Hadfield on Facebook
VP - Human Resources
Lynn Ferrucci
  Lynn Ferrucci LinkedIn Profile  Lynn Ferrucci Twitter Account  Lynn Ferrucci News  Lynn Ferrucci on Facebook
VP - Operations
Jill Buck
  Jill Buck LinkedIn Profile  Jill Buck Twitter Account  Jill Buck News  Jill Buck on Facebook



Browse more venture capital transactions:

Prev: 9/18/2019: Biproxi venture capital transaction
Next: 9/18/2019: FarmWise venture capital transaction


Share this article


About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary